Table 2.
Proportion of respondents selecting Level 1 and Level 3 clinical management strategies ‘always’ or ‘most of the time’, overall and stratified by each of the 8 clinical vignettes (N = 79)
| Level 1 strategies, % | Level 3 strategies, % | P value | |
|---|---|---|---|
|
Overall |
82 |
43 |
< 0.001 |
|
Clinical vignette scenario |
|
|
|
| Community acquired pneumonia |
93 |
25 |
< 0.001 |
| Acute coronary syndrome* |
93 |
65 |
< 0.001 |
| Congestive heart failure |
85 |
31 |
< 0.001 |
| Syncope |
83 |
33 |
< 0.001 |
| Asthma* |
81 |
52 |
< 0.001 |
| End-Stage lung cancer*† |
77 |
61 |
0.01 |
| Transient ischemic attack*† |
73 |
17 |
< 0.001 |
| Chronic obstructive pulmonary disease*† | 69 | 57 | 0.08 |
*Proportion of respondents that selected Level 3 clinical management strategies was significantly different that the proportion that selected Level 3 strategies for the community acquired pneumonia vignette.
†Proportion of respondents that selected Level 1 clinical management strategies was significantly different that the proportion that selected Level 1 strategies for the community acquired pneumonia vignette.